Skip to content
Center for Political Accountability
Bringing transparency & accountability to corporate political spending
Center for Political Accountability
  • CPA-Zicklin Index
    • Past CPA-Zicklin Index Reports
    • Purpose of CPA-Zicklin Index
  • News
    • In the News
    • Podcasts
    • Press Releases
    • CPA Newsletters
  • Reports
    • CPA Reports
    • Recent Shareholder Engagement
  • TrackYourCompany
    • Why Corporate Political Spending Matters
    • Where Does Our Data Come From?
    • How Companies Rank In The CPA-Zicklin Index
    • Shareholder Engagement History
  • Our Impact
  • About
    • CPA-Zicklin Model Code of Conduct for Corporate Political Spending
    • About Us
    • How Companies Spend
    • Citizens United and Dark Money
    • Board of Directors
    • CPA Advisory Council
    • Staff
    • Internships
  • Donate
Search:
  • CPA-Zicklin Index
    • Past CPA-Zicklin Index Reports
    • Purpose of CPA-Zicklin Index
  • News
    • In the News
    • Podcasts
    • Press Releases
    • CPA Newsletters
  • Reports
    • CPA Reports
    • Recent Shareholder Engagement
  • TrackYourCompany
    • Why Corporate Political Spending Matters
    • Where Does Our Data Come From?
    • How Companies Rank In The CPA-Zicklin Index
    • Shareholder Engagement History
  • Our Impact
  • About
    • CPA-Zicklin Model Code of Conduct for Corporate Political Spending
    • About Us
    • How Companies Spend
    • Citizens United and Dark Money
    • Board of Directors
    • CPA Advisory Council
    • Staff
    • Internships
  • Donate

Daily Archives: February 1, 2018

As States Target High Drug Prices, Pharma Targets State Lawmakers

In the NewsBy switzmanFebruary 1, 2018
Go to Top